Free tool
FAERS Monitor: Azilect
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021641 or its brand name (Azilect, Rasagiline Mesylate). Reports on generic versions are filed under their own applications.
Reports
11,264
Serious
7,507
67% of reports
Hospitalization
3,676
Death reported
1,255
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fall1,093
- hallucination986
- dyskinesia784
- drug ineffective772
- dizziness675
- tremor663
- death638
- confusional state561
- parkinson^s disease543
- gait disturbance536
- somnolence515
- nausea501
- fatigue482
- constipation433
- insomnia378
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 7 |
| 2007 | 66 |
| 2008 | 138 |
| 2009 | 95 |
| 2010 | 271 |
| 2011 | 268 |
| 2012 | 303 |
| 2013 | 437 |
| 2014 | 423 |
| 2015 | 590 |
| 2016 | 692 |
| 2017 | 897 |
| 2018 | 912 |
| 2019 | 1,045 |
| 2020 | 1,057 |
| 2021 | 911 |
| 2022 | 813 |
| 2023 | 521 |
| 2024 | 629 |
| 2025 | 634 |
| 2026 | 555 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,895 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dyskinesiaSignal | 784 | 36.7 | 34.3 | 26,725 |
| hallucinationSignal | 986 | 24.7 | 23.3 | 22,224 |
| tremorSignal | 663 | 7.5 | 7.0 | 3,733 |
| confusional stateSignal | 561 | 6.5 | 6.0 | 2,617 |
| fallSignal | 1,093 | 6.1 | 5.8 | 4,768 |
| gait disturbanceSignal | 536 | 5.2 | 4.8 | 1,847 |
| somnolenceSignal | 515 | 4.8 | 4.4 | 1,549 |
| constipationSignal | 433 | 3.7 | 3.4 | 863 |
| insomniaSignal | 378 | 2.7 | 2.4 | 392 |
| dizzinessSignal | 675 | 2.5 | 2.4 | 637 |
| death | 638 | 1.4 | 1.3 | 70 |
| nausea | 501 | 1.2 | 1.1 | 14 |
| fatigue | 482 | 1.2 | 1.1 | 10 |
| drug ineffective | 772 | 1.1 | 1.0 | 7 |
| parkinson^s disease | 543 | 0.0 | 0.0 | 1,012,566 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.